Page last updated: 2024-12-06

2,3-dihydrofuran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,3-Dihydrofuran is a heterocyclic organic compound with the formula C4H6O. It is a colorless liquid with a pungent odor. 2,3-Dihydrofuran is a versatile building block in organic synthesis and is used as a starting material for the production of various pharmaceuticals and other chemicals. The compound is known for its potential in the synthesis of biologically active compounds, such as anti-inflammatory agents, antifungal agents, and antibacterial agents. 2,3-Dihydrofuran is also studied for its potential applications in the development of novel materials, such as polymers and resins.'

dihydrofuran : Compounds containing a mono-unsaturated furan ring skeleton. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID70934
CHEBI ID51662
MeSH IDM0199453

Synonyms (35)

Synonym
nsc85221
4,5-dihydrofuran
1191-99-7
furan,3-dihydro-
nsc-85221
2,3-dihydrofuran
inchi=1/c4h6o/c1-2-4-5-3-1/h1,3h,2,4h
furan, 2,3-dihydro-
2,3-dihydrofuran, 99%
CHEBI:51662
D1415
AKOS000121127
36312-17-1
07m2ey3bg1 ,
nsc 85221
einecs 214-747-7
unii-07m2ey3bg1
dihydrofuran
STL146450
FT-0609660
furan, dihydro-
2,3 dihydrofuran
2,3-dhf
2,3dihydrofuran
2,3-dihydrofurane
2,3-dihydro-furan
DTXSID9061594
Q-200169
STR04249
F0001-0314
mfcd00003205
Q2813778
CS-0015741
EN300-26572
PD065538
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dihydrofuranCompounds containing a mono-unsaturated furan ring skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.13)18.7374
1990's1 (3.13)18.2507
2000's10 (31.25)29.6817
2010's17 (53.13)24.3611
2020's3 (9.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.53 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index5.60 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]